- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens, Philips win VA CR contract
In a move that brought two major multimodality vendors into collaboration, the Veterans Affairs Acquisition Center this month awarded Siemens Medical Systems and Philips Medical Systems North America a joint contract to provide computed radiography
In a move that brought two major multimodality vendors into collaboration, the Veterans Affairs Acquisition Center this month awarded Siemens Medical Systems and Philips Medical Systems North America a joint contract to provide computed radiography equipment and connectivity to seven VA hospitals. The $7 million contract is part of the Veterans Integrated Network System project, and includes six Southern California VA hospitals and one in Las Vegas.
Shelton, CT-based Philips will provide CR equipment, including RIS interfaces as well as film digitizers and printing capabilities. Iselin, NJ-based Siemens will supply workstations for CR review as well as archive servers with database management. The two firms expect the systems to be installed by the end of May.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
